Disclosure: I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours.I wrote this article myself, and it expresses my own opinions.Secondly, Roy Pitchford gave a long interview in which he seemed to be blaming the existing shareholders for not supporting the share price sufficiently in the first place. I am not sure it can sell all of those in the short-term due to volume constraints; however, one would imagine that Crede selling would add further downward pressure to the share price just in time for the second tranche of funding which can be drawn down at the start of April and the whole thing can happen all over again.By way of example, should the share price fall to 0.25p, Crede would then subscribe for 500m shares which would account for close to 20% of the issued share capital, which would now be in excess of 2.5 billion shares, from below 2 billion at the start.Did anyone signing up to this even understand this second option? This second option is set out in incredibly complex language, the main aim of which I imagine was to confuse management and shareholders alike.
So a risk-free annualised return of somewhere between 200% and 700%.
I am not receiving compensation for it (other than from Share Prophets).
I have no business relationship with any company whose stock is mentioned in this article.
provides data analytics based specialized behavioral health management and integrated treatment services to health plans.
It offers services through its platform On Trak solution which is designed to improve member health and, at the same time, lower costs to the insurer for underserved populations where behavioral health conditions cause or exacerbate co-existing medical conditions. Peizer in February 2003 and is headquartered in Los Angeles, CA.